跳至主要内容
临床试验/CTRI/2021/11/037748
CTRI/2021/11/037748尚未招募未知

Comparison of Ferric Citrate and Sevelamer in the Treatment of Hyperphosphatemia in patients with Chronic Kidney Disease stage 3 to 5D: A Randomized Controlled Non-inferiority Trial

il0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age > 18 years with eGFR < 60ml/min/1.73m2
  • 2. Patients who are not taking phosphate binders with serum phosphate level > 6mg/dl and < 10mg/dl
  • 3. Patients who had discontinued phosphate binders for > 2weeks with serum phosphate level > 6mg/dl and < 10mg/dl

排除标准

  • 1. Symptomatic gastrointestinal bleedin
  • 2. Patients with Inflammatory Bowel Disease, Peptic ulcer disease
  • 3. History of gastrectomy or any recent intestinal surgery
  • 4. Patients with marked constipation or severe gastrointestinal motility disorder.
  • 5. Known patients with Hemochromatosis.
  • 6. Patients diagnosed with chronic liver disease.
  • 7. Serum Ferritin >= 1000 ng/ml or Transferrin saturation > 55% during initial screening.
  • 8. Patients who had undergone parathyroidectomy.
  • 9. Patient with diagnosis of acute kidney injury superimposed on chronic kidney disease.
  • 10. Patients receiving inadequate/ irregular hemodialysis will be excluded.

研究者

发起方
il

相似试验